Skip to Main Content

Author Details

Patricia Fetsch
Center for Cancer Research, National Cancer Institute, National Institutes of Health
1994
76
36
PMIDPaper TitleJournal TitlePublished Year
37101182Correction: First-in-human phase 1 clinical trial of anti-core 1 O-glycans targeting monoclonal antibody NEO-201 in treatment-refractory solid tumors.J Exp Clin Cancer Res2023
36991390First-in-human phase 1 clinical trial of anti-core 1 O-glycans targeting monoclonal antibody NEO-201 in treatment-refractory solid tumors.J Exp Clin Cancer Res2023
37101182Correction: First-in-human phase 1 clinical trial of anti-core 1 O-glycans targeting monoclonal antibody NEO-201 in treatment-refractory solid tumors.J Exp Clin Cancer Res2023
36991390First-in-human phase 1 clinical trial of anti-core 1 O-glycans targeting monoclonal antibody NEO-201 in treatment-refractory solid tumors.J Exp Clin Cancer Res2023
34534680Molecular Subtypes of Primary SCLC Tumors and Their Associations With Neuroendocrine and Therapeutic Markers.J Thorac Oncol2022
34534680Molecular Subtypes of Primary SCLC Tumors and Their Associations With Neuroendocrine and Therapeutic Markers.J Thorac Oncol2022
34485830Neutrophil and Eosinophil Extracellular Traps in Hodgkin Lymphoma.Hemasphere2021
34485830Neutrophil and Eosinophil Extracellular Traps in Hodgkin Lymphoma.Hemasphere2021
32004714Sensitivity of Mesothelioma Cells to PARP Inhibitors Is Not Dependent on BAP1 but Is Enhanced by Temozolomide in Cells With High-Schlafen 11 and Low-O6-methylguanine-DNA Methyltransferase Expression.J Thorac Oncol2020
32004714Sensitivity of Mesothelioma Cells to PARP Inhibitors Is Not Dependent on BAP1 but Is Enhanced by Temozolomide in Cells With High-Schlafen 11 and Low-O6-methylguanine-DNA Methyltransferase Expression.J Thorac Oncol2020
30636524Immunophenotypic Characterization of Canine Splenic Follicular-Derived B-Cell Lymphoma.Vet Pathol2019
30636524Immunophenotypic Characterization of Canine Splenic Follicular-Derived B-Cell Lymphoma.Vet Pathol2019
30722027Low mutation burden and frequent loss of CDKN2A/B and SMARCA2, but not PRC2, define premalignant neurofibromatosis type 1-associated atypical neurofibromas.Neuro Oncol2019
30722027Low mutation burden and frequent loss of CDKN2A/B and SMARCA2, but not PRC2, define premalignant neurofibromatosis type 1-associated atypical neurofibromas.Neuro Oncol2019
28789475Expression of CD70 (CD27L) Is Associated With Epithelioid and Sarcomatous Features in IDH-Wild-Type Glioblastoma.J Neuropathol Exp Neurol2017
28933335Re-evaluating TTF-1 immunohistochemistry in diffuse gliomas: Expression is clone-dependent and associated with tumor location.Clin Neuropathol2017
28789475Expression of CD70 (CD27L) Is Associated With Epithelioid and Sarcomatous Features in IDH-Wild-Type Glioblastoma.J Neuropathol Exp Neurol2017
28933335Re-evaluating TTF-1 immunohistochemistry in diffuse gliomas: Expression is clone-dependent and associated with tumor location.Clin Neuropathol2017
26999048High-Throughput Microdissection for Next-Generation Sequencing.PLoS One2016
26999048High-Throughput Microdissection for Next-Generation Sequencing.PLoS One2016
26820614Human-Mouse Chimeras with Normal Expression and Function Reveal That Major Domain Swapping Is Tolerated by P-Glycoprotein (ABCB1).Biochemistry2016
26459178Mithramycin Depletes Specificity Protein 1 and Activates p53 to Mediate Senescence and Apoptosis of Malignant Pleural Mesothelioma Cells.Clin Cancer Res2016
26459178Mithramycin Depletes Specificity Protein 1 and Activates p53 to Mediate Senescence and Apoptosis of Malignant Pleural Mesothelioma Cells.Clin Cancer Res2016
26820614Human-Mouse Chimeras with Normal Expression and Function Reveal That Major Domain Swapping Is Tolerated by P-Glycoprotein (ABCB1).Biochemistry2016
25411763Antibody αPEP13h reacts with lymphangioleiomyomatosis cells in lung nodules.Chest2015
25411763Antibody αPEP13h reacts with lymphangioleiomyomatosis cells in lung nodules.Chest2015
23161830Adenocarcinoma cells in effusion cytology as a diagnostic pitfall with potential impact on clinical management: a case report with brief review of immunomarkers.Diagn Cytopathol2014
23161830Adenocarcinoma cells in effusion cytology as a diagnostic pitfall with potential impact on clinical management: a case report with brief review of immunomarkers.Diagn Cytopathol2014
24647571Human melanoma metastases demonstrate nonstochastic site-specific antigen heterogeneity that correlates with T-cell infiltration.Clin Cancer Res2014
24647571Human melanoma metastases demonstrate nonstochastic site-specific antigen heterogeneity that correlates with T-cell infiltration.Clin Cancer Res2014
23554410Kba.62 and S100 protein expression in cytologic samples of metastatic malignant melanoma.Diagn Cytopathol2013
23807161IRF-1 responsiveness to IFN-γ predicts different cancer immune phenotypes.Br J Cancer2013
23554410Kba.62 and S100 protein expression in cytologic samples of metastatic malignant melanoma.Diagn Cytopathol2013
23807161IRF-1 responsiveness to IFN-γ predicts different cancer immune phenotypes.Br J Cancer2013
22028491Polycomb repressor complex-2 is a novel target for mesothelioma therapy.Clin Cancer Res2012
22751465Mithramycin represses basal and cigarette smoke-induced expression of ABCG2 and inhibits stem cell signaling in lung and esophageal cancer cells.Cancer Res2012
23225411Loss of mesothelin expression by mesothelioma cells grown in vitro determines sensitivity to anti-mesothelin immunotoxin SS1P.Anticancer Res2012
23207440Semiautomated laser capture microdissection of lung adenocarcinoma cytology samples.Acta Cytol2012
22028491Polycomb repressor complex-2 is a novel target for mesothelioma therapy.Clin Cancer Res2012
23207440Semiautomated laser capture microdissection of lung adenocarcinoma cytology samples.Acta Cytol2012
23225411Loss of mesothelin expression by mesothelioma cells grown in vitro determines sensitivity to anti-mesothelin immunotoxin SS1P.Anticancer Res2012
22751465Mithramycin represses basal and cigarette smoke-induced expression of ABCG2 and inhibits stem cell signaling in lung and esophageal cancer cells.Cancer Res2012
20012854The clinical immunohistochemistry laboratory: regulations and troubleshooting guidelines.Methods Mol Biol2010
20012854The clinical immunohistochemistry laboratory: regulations and troubleshooting guidelines.Methods Mol Biol2010
19135109ABCG2: a perspective.Adv Drug Deliv Rev2009
19135109ABCG2: a perspective.Adv Drug Deliv Rev2009
19330028Analysis of the matrix metalloproteinase family reveals that MMP8 is often mutated in melanoma.Nat Genet2009
19330028Analysis of the matrix metalloproteinase family reveals that MMP8 is often mutated in melanoma.Nat Genet2009
17222352Sequential gene profiling of basal cell carcinomas treated with imiquimod in a placebo-controlled study defines the requirements for tissue rejection.Genome Biol2007
17222352Sequential gene profiling of basal cell carcinomas treated with imiquimod in a placebo-controlled study defines the requirements for tissue rejection.Genome Biol2007
  • 1 - 50 of 152

Recommended Authors

Hubert D Lau
Stanford University School of Medicine
Career Start Year 2010
Number of shared co-authors 0
Raghwa Sharma
Westmead Hospital
Career Start Year 2004
Number of shared co-authors 0
Joerg Schwock
University of Toronto
Career Start Year 2003
Number of shared co-authors 0
Marcory C R F van Dijk
1Rijnstate Hospital
Career Start Year 2001
Number of shared co-authors 0
Travis J Hollmann
Memorial Sloan Kettering Cancer Center
Career Start Year 1998
Number of shared co-authors 0
Kelly Bethel
Scripps Clinic Medical Group
Career Start Year 1995
Number of shared co-authors 0
Elizabeth L Salisbury
Prince of Wales Hospital
Career Start Year 1995
Number of shared co-authors 3
Sanjay Navani
Breach Candy Hospital and Research Centre
Career Start Year 1995
Number of shared co-authors 0
William J Howat
Cancer Research UK Cambridge Institute
Career Start Year 1994
Number of shared co-authors 3
Michael Bzorek
Zealand University Hospital
Career Start Year 1994
Number of shared co-authors 0
Jon H Ritter
Washington University School of Medicine
Career Start Year 1993
Number of shared co-authors 0
Jason L Hornick
Brigham and Women's Hospital and Harvard Medical School
Career Start Year 1993
Number of shared co-authors 3
Vijayalakshmi Padmanabhan
Baylor College of Medicine
Career Start Year 1993
Number of shared co-authors 0
Bhaskar Kallakury
Georgetown University
Career Start Year 1993
Number of shared co-authors 3
Sarah M Dry
Jonsson Comprehensive Cancer Center, University of California los angeles
Career Start Year 1992
Number of shared co-authors 0
Alexander J Lazar
The University of Texas MD Anderson Cancer Center
Career Start Year 1989
Number of shared co-authors 9
Jose A Lopez-Martin
Hospital Universitario 12 de Octubre
Career Start Year 1988
Number of shared co-authors 2
Christina S Kong
Stanford University School of Medicine
Career Start Year 1988
Number of shared co-authors 1
Juan P Palazzo
Thomas Jefferson University Hospital
Career Start Year 1988
Number of shared co-authors 6
Cyril B Gilks
University of British Columbia
Career Start Year 1987
Number of shared co-authors 1
Silvano Bosari
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Career Start Year 1986
Number of shared co-authors 3
Ossama Tawfik
University of Kansas
Career Start Year 1985
Number of shared co-authors 0
Rex C Bentley
Duke School of Medicine
Career Start Year 1984
Number of shared co-authors 0
Jahn M Nesland
The Norwegian Radium Hospital, Oslo University Hospital
Career Start Year 1980
Number of shared co-authors 0
David L Rimm
Yale University School of Medicine
Career Start Year 1980
Number of shared co-authors 1
Bernard T??tu
Centre de Recherche du CHU de Quebec-Universite Laval (axe Oncologie)
Career Start Year 1979
Number of shared co-authors 0
Bogdan Czerniak
University of Texas MD Anderson Cancer Center
Career Start Year 1975
Number of shared co-authors 3
Jeffrey S Ross
Foundation Medicine
Career Start Year 1974
Number of shared co-authors 0
William E Grizzle
University of Alabama at Birmingham
Career Start Year 1974
Number of shared co-authors 1
William A Robinson
National Centre for Asbestos Related Diseases, University of Western Australia
Career Start Year 1967
Number of shared co-authors 6

Collaborators

Armando C Filie
National Cancer Institute, National Institutes of Health
Co-authored papers 20
Steven A Rosenberg
University of Colorado School of Medicine
Co-authored papers 12
Janice N Cormier
Co-authored papers 6
Seth M Steinberg
Center for Cancer Research, National Cancer Institute
Co-authored papers 6
Markku Miettinen
National Cancer Institute
Co-authored papers 5
David S Schrump
Center for Cancer Research, National Cancer Institute
Co-authored papers 4
Mark Raffeld
Center for Cancer Research, National Cancer Institute
Co-authored papers 4
Mahadev Rao
Department of Pharmacy Practice, Manipal College of Pharmaceutical Sciences
Co-authored papers 3
Mary Zhang
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 3
John R Wunderlich
National Cancer Institute
Co-authored papers 3
Julie A Hong
National Cancer Institute, National Institutes of Health
Co-authored papers 3
Michael R Emmert-Buck
The Francis Crick Institute
Co-authored papers 3
Stefania Pittaluga
National Cancer Institute, National Institutes of Health
Co-authored papers 3
Nicholas P Restifo
National Cancer Institute, National Institutes of Health (NIH)
Co-authored papers 2
Martha Quezado
National Cancer Institute (NCI), National Institutes of Health (NIH)
Co-authored papers 2
Paul H Duray
National Cancer Institute, National Institutes of Health
Co-authored papers 2
Yves Pommier
Center for Cancer Research, National Cancer Institute
Co-authored papers 2
Michael Dean
National Cancer Institute
Co-authored papers 2
Itzhak Avital
Goldman School of Medicine, Ben Gurion University
Co-authored papers 2
Sichuan Xi
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 2
Drew Pratt
Co-authored papers 2
Raphael Bueno
Co-authored papers 2
Jason D Hipp
Mayo Clinic
Co-authored papers 2
Stanley Lipkowitz
Center for Cancer Research, National Cancer Institute
Co-authored papers 2
Maryalice Stetler-Stevenson
National Cancer Institute, National Institutes of Health
Co-authored papers 1
Elaine S Jaffe
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 1
Maocheng Yang
College of Basic Medicine, Army Medical University
Co-authored papers 1
Vincent J Hearing
Co-authored papers 1
Raj Chari
The National Institutes of Health
Co-authored papers 1
Patricia Porter-Gill
Arkansas Children's Research Institute
Co-authored papers 1
Release 1.2